Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
729,788
-
Share change
-
-53,513
-
Total reported value
-
$128,295,664
-
Put/Call ratio
-
0%
-
Price per share
-
$175.28
-
Number of holders
-
124
-
Value change
-
-$9,783,894
-
Number of buys
-
45
-
Number of sells
-
42
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2023
As of 31 Mar 2023,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
124 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
729,788 shares.
The largest 10 holders included
MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, Royal Bank of Canada, Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, BROWN ADVISORY INC, RiverFront Investment Group, LLC, UBS Group AG, LPL Financial LLC, and ENVESTNET ASSET MANAGEMENT INC.
This page lists
127
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.